Tolperisone (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tolperisone" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

5doi.org

2^nd place

3europa.eu

68^th place

117^th place

2semanticscholar.org

11^th place

8^th place

1web.archive.org

1^st place

1info-medic.ro

low place

doi.org (Global: 2^nd place; English: 2^nd place)

Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W (2008-05-14). "Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects". CNS Neuroscience & Therapeutics. 14 (2): 107–119. doi:10.1111/j.1527-3458.2008.00044.x. PMC 6494009. PMID 18482024.
Ribi C, Vermeulen C, Hauser C (June 2003). "Anaphylactic reactions to tolperisone (Mydocalm)". Swiss Medical Weekly. 133 (25–26): 369–371. doi:10.4414/smw.2003.10280. PMID 12947534. S2CID 24540050.
Sporkert F, Brunel C, Augsburger MP, Mangin P (February 2012). "Fatal tolperisone poisoning: autopsy and toxicology findings in three suicide cases". Forensic Science International. 215 (1–3): 101–104. doi:10.1016/j.forsciint.2011.05.025. PMID 21683537.
Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, et al. (December 2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels". The Journal of Pharmacology and Experimental Therapeutics. 315 (3): 1237–1246. doi:10.1124/jpet.105.089805. PMID 16126840. S2CID 13020517.
Hofer D, Lohberger B, Steinecker B, Schmidt K, Quasthoff S, Schreibmayer W (May 2006). "A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms". European Journal of Pharmacology. 538 (1–3): 5–14. doi:10.1016/j.ejphar.2006.03.034. PMID 16650844.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"Tolperisone - referral | European Medicines Agency". www.ema.europa.eu. 22 June 2012. Retrieved 2024-03-04.
"Referral procedures". European Medicines Agency. 17 September 2018. Retrieved 2022-11-20.
"Tolperisone". European Medicines Agency. 17 September 2018. Retrieved 2022-11-20.

info-medic.ro (Global: low place; English: low place)

"Midocalm". Romania: InfoMedic. Archived from the original on 2014-07-30. Retrieved 2013-09-21.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W (2008-05-14). "Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects". CNS Neuroscience & Therapeutics. 14 (2): 107–119. doi:10.1111/j.1527-3458.2008.00044.x. PMC 6494009. PMID 18482024.
Ribi C, Vermeulen C, Hauser C (June 2003). "Anaphylactic reactions to tolperisone (Mydocalm)". Swiss Medical Weekly. 133 (25–26): 369–371. doi:10.4414/smw.2003.10280. PMID 12947534. S2CID 24540050.
Kwaśniewski A, Korbuszewska-Gontarz B, Mika S (2003). "[Mydocalm causing anaphylaxis]". Pneumonologia I Alergologia Polska (in Polish). 71 (5–6): 250–252. PMID 14587432.
Glück J, Rymarczyk B, Rogala B (2011). "An immediate hypersensitivity reaction caused by tolperisone hydrochloride". Journal of Investigational Allergology & Clinical Immunology. 21 (5): 411–412. PMID 21905508.
Sporkert F, Brunel C, Augsburger MP, Mangin P (February 2012). "Fatal tolperisone poisoning: autopsy and toxicology findings in three suicide cases". Forensic Science International. 215 (1–3): 101–104. doi:10.1016/j.forsciint.2011.05.025. PMID 21683537.
Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, et al. (December 2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels". The Journal of Pharmacology and Experimental Therapeutics. 315 (3): 1237–1246. doi:10.1124/jpet.105.089805. PMID 16126840. S2CID 13020517.
Hofer D, Lohberger B, Steinecker B, Schmidt K, Quasthoff S, Schreibmayer W (May 2006). "A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms". European Journal of Pharmacology. 538 (1–3): 5–14. doi:10.1016/j.ejphar.2006.03.034. PMID 16650844.

ncbi.nlm.nih.gov

Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W (2008-05-14). "Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects". CNS Neuroscience & Therapeutics. 14 (2): 107–119. doi:10.1111/j.1527-3458.2008.00044.x. PMC 6494009. PMID 18482024.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Ribi C, Vermeulen C, Hauser C (June 2003). "Anaphylactic reactions to tolperisone (Mydocalm)". Swiss Medical Weekly. 133 (25–26): 369–371. doi:10.4414/smw.2003.10280. PMID 12947534. S2CID 24540050.
Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, et al. (December 2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels". The Journal of Pharmacology and Experimental Therapeutics. 315 (3): 1237–1246. doi:10.1124/jpet.105.089805. PMID 16126840. S2CID 13020517.

web.archive.org (Global: 1^st place; English: 1^st place)

"Midocalm". Romania: InfoMedic. Archived from the original on 2014-07-30. Retrieved 2013-09-21.

Tolperisone (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

europa.eu (Global: 68th place; English: 117th place)